Reaching Out to Improve Access to Radiation Therapy Treatment: Xstrahl attends regional conferences to meet with clinicians and discuss radiation therapy
Reaching Out to Improve Access to Radiation Therapy
read more
News
Xstrahl to feature Radiant™ Aura at ASTRO 2023
Xstrahl, a global leader in the delivery of superficial radiation therapy devices and preclinical radiation research systems, will demonstrate Radiant Aura, a new low-dose, X-ray based, dual modality radiation therapy for treating non-melanoma skin cancers (NMSC) and keloid scarring at the American Society for Therapeutic Radiology and Oncology (ASTRO) Annual Meeting in San Diego, CA, October 1-3, 2023, booth #2216.
Xstrahl & SmART Scientific Solutions to showcase two new software solutions for radiation research at ICRR in Montréal, Canada
Xstrahl & SmART Scientific Solutions to showcase two new software solutions for radiation research at ICRR in Montréal, Canada
Xstrahl will demonstrate SmART-RAD and SmART-Contour at the 17th International Congress for Radiation Research (ICRR) August 27-30
Radiant™ Aura Receives U.S. Food and Drug Administration (FDA) 510(k) Clearance
Radiant™ Aura Receives U.S. Food and Drug Administration (FDA) 510(k) Clearance
Expands office-based treatment options for millions of non-melanoma skin cancer (NMSC) patients
Xstrahl, a global leader in the delivery of superficial radiation therapy devices and preclinical radiation research systems, announced its Radiant™ Aura treatment solution has received U.S. Food and Drug Administration (FDA) 510(k) clearance. With advanced features for expanded clinical use, simplified patient positioning, and additional patient comfort, Radiant Aura brings radiation therapy to NMSC patients in any dermatology office.
Xstrahl Delivers CIX FLASH, the First Commercial X-Ray Based Preclinical FLASH Irradiator
Xstrahl Delivers CIX FLASH, the First Commercial X-Ray Based Preclinical FLASH Irradiator CIX FLASH supports translational research into current and expanded FLASH radiotherapy techniques Xstrahl announced today the first delivery of CIX FLASH, the world’s first...
New Cross Hospital Modernizes Cancer Treatment with Radiotherapy System
New Cross Hospital, based in Wolverhampton, England, recently announced the installation of the Xstrahl 200 radiotherapy system to treat skin cancer and gynecological cancers. More information is available online at the BBC. The hospital staff described how this...
FLASH Forward: Looking Ahead to Preclinical FLASH Radiotherapy Studies
Xstrahl is proud to connect investigators from diverse audiences – including academic institutions, research hospitals, CROs, biotech and pharmaceutical companies, and countless interdisciplinary teams – to inspire science and advance care with successful preclinical...
Xstrahl User Helps Pilot Virtual Multidisciplinary Clinic
Based on the study, Experiences with a pilot electronic skin multidisciplinary clinic for complex skin cancer, clinicians, including a long-time Xstrahl user, collaborated to develop a pilot mutlidisciplinary clinic, or eMDT. See more below and the full article here....
MuriSuite: Coming in 2022
We are thrilled to announce that MuriSuite, a brand new control system for all SARRP devices, will be released this year. Hear more in this video from our CEO, Adrian Treverton and our resident SARRP expert, Wilfried Goetz. https://vimeo.com/710478777
Contact Us